524711
VISTAPH
Invest Now
Start SIP in
VISTAPH
Performance
- Low
- ₹10
- High
- ₹11
- 52 Week Low
- ₹9
- 52 Week High
- ₹17
- Open Price₹11
- Previous Close₹11
- Volume1,580
Investment Returns
- Over 1 Month + 0.54%
- Over 3 Month + 14.01%
- Over 6 Month -15.5%
- Over 1 Year -20.93%
Smart Investing Starts Here Start SIP with Vista Pharmaceuticals for Steady Growth!
Vista Pharmaceuticals Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- -22.3
- PEG Ratio
- -0.3
- Market Cap Cr
- 68
- P/B Ratio
- 1.6
- Average True Range
- 0.74
- EPS
- -
- Dividend Yield
- 0
- MACD Signal
- 0.07
- RSI
- 48.72
- MFI
- 39.15
Vista Pharmaceuticals Financials
Vista Pharmaceuticals Technicals
EMA & SMA
Current Price
₹11.07
+
0.22
(2.03%)

-
- Bearish Moving Average 12
-
- Bullish Moving Average 4
- 20 Day
- ₹11.19
- 50 Day
- ₹11.09
- 100 Day
- ₹11.24
- 200 Day
- ₹11.79
Resistance and Support
10.86
- R3 12.18
- R2 11.67
- R1 11.37
- S1 10.56
- S2 10.05
- S3 9.75
Vista Pharmaceuticals Corporate Actions - Bonus, Splits, Dividends
Date | Purpose | Remarks |
---|---|---|
2025-02-19 | Preferential Issue of shares & Others | Inter-alia, to consider 1. Notice of the EGM for the approval of raising of funds. 2. Other business matters. |
2025-02-12 | Quarterly Results | |
2024-11-13 | Quarterly Results | |
2024-08-13 | Quarterly Results | |
2024-05-28 | Audited Results |
Vista Pharmaceuticals F&O
About Vista Pharmaceuticals
- NSE Symbol
- VISTAPH
- BSE Symbol
- 524711
- Managing Director
- Mr. Murali Meraga
- ISIN
- INE427C01021
Similar Stocks to Vista Pharmaceuticals
Vista Pharmaceuticals FAQs
Vista Pharmaceuticals share price is ₹11 As on 03 May, 2025 | 00:13
The Market Cap of Vista Pharmaceuticals is ₹68.1 Cr As on 03 May, 2025 | 00:13
The P/E ratio of Vista Pharmaceuticals is -22.3 As on 03 May, 2025 | 00:13
The PB ratio of Vista Pharmaceuticals is 1.6 As on 03 May, 2025 | 00:13
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.